Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

LON/0R34 stock hub

LON/0R34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0R34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
391B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0R34
In the news

Latest news · LON/0R34

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6
P25 n/aP50 n/aP75 n/a
Trailing P/E24.7
P25 n/aP50 n/aP75 n/a
ROE26.4
P25 n/aP50 n/aP75 n/a
ROIC19.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0R34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
218
Groups with data
11
Currency
USD
Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
UK
Employees
138,200
Employees Change
100%
Employees Change Percent
0.07
Enterprise value
$415.2B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Isin
US4781601046
Last refreshed
2026-05-10
Market cap
$391B
Price
$222
Price currency
USD
Rev Per Employee
524,670.87x
Sic
2834
Symbol
lon/0R34
Website
https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.05%
EV Earnings
26.22x
EV/EBIT
21.27x
EV/EBITDA
16.39x
EV/FCF
31.02x
EV/Sales
5.87x
FCF yield
3.42%
Forward P/E
18.56x
P/B ratio
6.4x
P/E ratio
24.7x
P/S ratio
5.39x
PE Ratio10 Y
45.82x
PE Ratio3 Y
18.63x
PE Ratio5 Y
21.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
27.59%
EBITDA Margin
35.62%
FCF margin
18.46%
Gross margin
68.04%
Gross Profit
$49.3B
Gross Profit Growth
6.69%
Gross Profit Growth Q
9.85%
Gross Profit Growth3 Y
6.7%
Gross Profit Growth5 Y
3.28%
Net Income
$15.8B
Net Income Growth
-3.53%
Net Income Growth Q
-52.41%
Net Income Growth3 Y
18.25%
Net Income Growth5 Y
6.84%
Pretax Margin
25.88%
Profit Margin
21.83%
Profit Per Employee
$114,558
ROA
8.42
Roa5y
8.04
ROCE
18.57
ROE
26.42
Roe5y
24.21
ROIC
19.95
Roic5y
23.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr1y
45.36%
Div CAGR10
20.46%
Div CAGR3
0.99%
Div CAGR5
4.68%
EPS Growth
-3.89
EPS Growth Q
-52.86
EPS Growth3 Y
21.64
EPS Growth5 Y
8.81
FCF Growth
-12.7%
FCF Growth Q
-56.64%
FCF Growth3 Y
3.14%
FCF Growth5 Y
-3.13%
OCF Growth
-7.72%
OCF Growth Q
-39.77%
OCF Growth10 Y
1.93%
OCF Growth3 Y
3.76%
OCF Growth5 Y
-1.17%
Revenue Growth
7.87x
Revenue Growth Q
9.91x
Revenue Growth3 Y
7.55x
Revenue Growth5 Y
2.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
$0.49
Assets
$151.2B
Cash
$16.6B
Current Assets
$43.4B
Current Liabilities
$42.3B
Debt
$41.4B
Debt EBITDA
$1.59
Debt Equity
$0.68
Debt FCF
$3.09
Equity
$61.1B
Interest Coverage
25.59
Liabilities
$90.1B
Long Term Assets
$107.8B
Long Term Liabilities
$47.7B
Net Cash
$-24.8B
Net Cash By Market Cap
$-6.34
Net Debt EBITDA
$0.96
Net Debt Equity
$0.41
Net Debt FCF
$1.85
Tangible Book Value
$-12.4B
Tangible Book Value Per Share
$-5.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.03
Inventory Turnover
2.26
Net Working Capital
$-2.4B
Quick ratio
0.69
Working Capital
$1.1B
Working Capital Turnover
$9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.29%
Dividend Growth
-0.3%
Dividend Growth Years
4%
Dividend per share
$3.87
Dividend Years
9
Dividend Yield
1.75%
Ex Div Date
2026-02-24
Last Dividend
$0.96
Payout Frequency
Quarterly
Payout Ratio
59.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
45.32%
200-day SMA
207.5
50-day SMA
236.5
50-day SMA vs 200-day SMA
50over200
All Time High
251.9
All Time High Change
-11.95%
All Time High Date
2026-03-02
All Time Low
140.7
All Time Low Change
57.67%
All Time Low Date
2025-01-10
ATR
5.83
Ch YTD
6.99
High
223.8
High52
251.9
High52 Date
2026-03-02
High52ch
-11.95%
Low
220
Low52
146.1
Low52 Date
2025-05-14
Low52ch
51.78%
Ma50ch
-6.2%
Price vs 200-day SMA
6.9%
RSI
35.43
RSI Monthly
67.42
RSI Weekly
51.31
Sharpe ratio
2.04x
Sortino ratio
3.66
Total Return
1.46%
Tr YTD
7.56
Tr1m
-7.25%
Tr1w
-2.77%
Tr3m
-7.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
$20B
Operating Income Growth
17.5
Operating Income Growth Q
4.05
Operating Income Growth3 Y
6.76
Operating Income Growth5 Y
4.61
Operating margin
27.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
2,403,389,742%
Net Borrowing
1,320,325,200
Shares Insiders
0.04%
Shares Institutions
75.42%
Shares Qo Q
0.25%
Shares Yo Y
0.29%
Short Ratio
2.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$12.4B
Average Volume
28,126.65x
Bv Per Share
25.38
CAPEX
$-3.8B
Ch1m
-7.25
Ch1w
-2.77
Ch1y
41.37
Ch3m
-7.52
Ch6m
18.78
Change
-0.29%
Change From Open
-0.42
Close
222.5
Days Gap
0.13
Depreciation Amortization
5,673,730,790
Dollar Volume
890,123.5
Earnings Date
2026-04-14
EBIT
$20B
EBITDA
$25.8B
EPS
$6.5
F Score
5
FCF
$13.4B
FCF EV Yield
3.22x
Financing CF
-11,611,364,570
Fiscal Year End
December
Founded
1,886
Goodwill
35,617,972,812
Graham Number
83.68817
Graham Upside
-62.27
Income Tax
$2.9B
Investing CF
-18,308,347,570
Is Primary Listing
0
Last Earnings Date
2026-04-14
Last Report Date
2026-03-29
Lynch Fair Value
$61.42
Lynch Upside
-72.31
Ma150
218.2
Ma150ch
1.63%
Ma20
229.1
Ma20ch
-3.19%
Net CF
-12,630,961,420
Next Earnings Date
2026-07-14
Open
222.7
P FCF Ratio
29.22
P OCF Ratio
22.72
Payment Date
2026-03-10
Position In Range
47.63
Ppne
17,068,870,780
Price Date
2026-05-08
Price EBITDA
$15.14
Relative Volume
0.14x
Revenue
72,509,514,140x
SBC By Revenue
1.42x
Share Based Comp
1,027,874,020
Tax By Revenue
4.05x
Tax Rate
15.64%
Tr6m
20.17%
Volume
4,013
Z Score
4.38
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

LON/0R34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.7%
$3.87 annual per share
Payout ratio
+59.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+4.7%
4 consecutive years of growth
Total shareholder yield
+1.5%
Next ex-dividend date: 2026-02-24
Performance

LON/0R34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+45.3%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0R34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+75.4%
Share of float held by funds and institutions
Insider ownership
+0.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.4 days to cover
Y/Y dilution
+0.3%
Negative means the company is buying back shares.
Technical

LON/0R34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
35.4
Neutral momentum band
Price vs 200-day MA
+6.9%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
2.04
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0R34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R34 stock rating?

lon/0R34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R34 analysis?

The full report lives at /stocks/lon/0R34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R34?

The latest report frames lon/0R34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.